Abstract:Angiotensin II (AngII) type 1 receptor (AT1-R) can be activated by mechanical stress (MS) without the involvement of AngII during the development of cardiomyocyte hypertrophy, in which G protein-independent pathways are critically involved. Although β-arrestin2-biased signaling has been speculated, little is known about how AT1-R/β-arrestin2 leads to ERK1/2 activation. Here, we present a novel mechanism by which Src kinase mediates AT1-R/β-arrestin2-dependent ERK1/2 phosphorylation in response to MS. Differing from stimulation by AngII, MS-triggered ERK1/2 phosphorylation is neither suppressed by overexpression of RGS4 (the negative regulator of the G-protein coupling signal) nor by inhibition of Gαq downstream protein kinase C (PKC) with GF109203X. The release of inositol 1,4,5-triphosphate (IP3) is increased by AngII but not by MS. These results collectively suggest that MS-induced ERK1/2 activation through AT1-R might be independent of G-protein coupling. Moreover, either knockdown of β-arrestin2 or overexpression of a dominant negative mutant of β-arrestin2 prevents MS-induced activation of ERK1/2. We further identifies a relationship between Src, a non-receptor tyrosine kinase and β-arrestin2 using analyses of co-immunoprecipitation and immunofluorescence after MS stimulation. Furthermore, MS-, but not AngII-induced ERK1/2 phosphorylation is attenuated by Src inhibition, which also significantly improves pressure overload-induced cardiac hypertrophy and dysfunction in mice lacking AngII. Finally, MS-induced Src activation and hypertrophic response are abolished by candesartan but not by valsartan whereas AngII-induced responses can be abrogated by both blockers. Our results suggest that Src plays a critical role in MS-induced cardiomyocyte hypertrophy through β-arrestin2-associated angiotensin II type 1 receptor signaling.

Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells

Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation.

Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells.

Role of Mitogen-Activated Protein Kinase in Myocardial Hypertrophy

Increased Myocardial Stiffness Activates Cardiac Microvascular Endothelial Cell Via VEGF Paracrine Signaling in Cardiac Hypertrophy

ERK1/2 and SAPK/JNK signaling pathways mediate Ang II-induced rat vascular smooth muscle cells proliferation via monocyte chemoattractant protein-1 expression

Pathogenesis of cardiovascular disease: Regulation of extracellular signal-regulated kinase on angiotensin II-induced proliferation of vascular smooth muscle cells

Crosstalk between Src and β-arrestin2 orchestrates cardiac hypertrophic responses under mechanical stresses

Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy

Angiotensin Ii Stimulates Protein Kinase D-Dependent Histone Deacetylase 5 Phosphorylation and Nuclear Export Leading to Vascular Smooth Muscle Cell Hypertrophy

Role of Ras/PKCζ/MEK/ERK1/2 Signaling Pathway in Angiotensin II-induced Vascular Smooth Muscle Cell Proliferation

Endothelial MRTF-A Mediates Angiotensin II Induced Cardiac Hypertrophy.

DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.

ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation

Regulation of angiotensin II-Induced Krüppel-like factor 5 expression in vascular smooth muscle cells.

Src is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy Through Angiotensin II Type 1 Receptor-Dependent Β-Arrestin2 Pathways.

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

A novel mechanism of mechanical stress-induced hypertrophy.

Angiotensin Ii Promotes Smooth Muscle Cell Proliferation and Migration Through Release of Heparin-Binding Epidermal Growth Factor and Activation of Egf-Receptor Pathway

Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension

Acute Hypertension Activates Mitogen-Activated Protein Kinases in Arterial Wall.